Literature DB >> 14675725

Poor and protracted myelination as a contributory factor to neurodegenerative disorders.

Heiko Braak1, Kelly Del Tredici.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14675725     DOI： 10.1016/j.neurobiolaging.2003.04.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN： 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  56 in total

1.  Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons.

Authors:  Amandine Berthet; Elyssa B Margolis; Jue Zhang; Ivy Hsieh; Jiasheng Zhang; Thomas S Hnasko; Jawad Ahmad; Robert H Edwards; Hiromi Sesaki; Eric J Huang; Ken Nakamura
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

2.  Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations.

Authors:  Eduardo M Castaño; Chera L Maarouf; Terence Wu; Maria Celeste Leal; Charisse M Whiteside; Lih-Fen Lue; Tyler A Kokjohn; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  Neurochem Int       Date:  2012-12-08       Impact factor: 3.921

Review 3.  [Pathogenesis and prevention of Alzheimer's disease: when and in what way does the pathological process begin?].

Authors:  H Braak; S Feldengut; K Del Tredici
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 4.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 5.  Heterogeneity of dopamine release sites in health and degeneration.

Authors:  Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2019-11-05       Impact factor: 5.996

Review 6.  Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson's Disease: Therapeutic Rationale and Current Status.

Authors:  Tara Swart; Michael J Hurley
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

7.  Whole-Transcriptome Analysis of Mouse Models with MPTP-Induced Early Stages of Parkinson's Disease Reveals Stage-Specific Response of Transcriptome and a Possible Role of Myelin-Linked Genes in Neurodegeneration.

Authors:  A Kh Alieva; V S Zyrin; M M Rudenok; A A Kolacheva; M V Shulskaya; M V Ugryumov; P A Slominsky; M I Shadrina
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

8.  Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Authors:  Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

9.  Evaluation of blastomere biopsy using a mouse model indicates the potential high risk of neurodegenerative disorders in the offspring.

Authors:  Yang Yu; Jindao Wu; Yong Fan; Zhuo Lv; Xuejiang Guo; Chun Zhao; Rong Zhou; Zhuo Zhang; Fuqiang Wang; Min Xiao; Ling Chen; Hui Zhu; Wen Chen; Min Lin; Jiayin Liu; Zuomin Zhou; Liu Wang; Ran Huo; Qi Zhou; Jiahao Sha
Journal:  Mol Cell Proteomics       Date:  2009-03-11       Impact factor: 5.911

10.  Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk.

Authors:  Kristen M Kennedy; Naftali Raz
Journal:  Brain Res       Date:  2009-08-25       Impact factor: 3.252
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.